Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Proton3on Oct 01, 2021 11:28am
133 Views
Post# 33952320

RE:Covid testing on an upswing and Aristotle testing confirmed

RE:Covid testing on an upswing and Aristotle testing confirmedIts not about just Oncore I wish it was, it's about missing every single solitary target he pumped to the shareholders by miles for years. Coming off an 80% revenue drop in 1 quarter doesn't help either. But we should listen to you and your phenonimal predictions!
StageZero Life Sciences Ltd. common share purchase warrants > Panic selling leads to sour grapes.

 1

April 01, 2021 - 03:33 PM
75 Reads
Post# 32924614

Panic selling leads to sour grapes.

Too bad, so sad.
Meanwhile, I've tripled my holdings in SZLS today.
Bathe me in your envy!
GLTA!

 
StageZero Life Sciences Ltd. common share purchase warrants > Amazing revenue growth, and still growing!!

 1

April 01, 2021 - 06:15 PM
202 Reads
Post# 32925410

Amazing revenue growth, and still growing!!

Tripp is a star!
Imagine having the vision to turn this small set of labs with a plan for a cancer bloodscreen into a wildly profitable, international set of labs with their top technologies fully launched!
And we aren't even seeing the real revenues from home testing for Covid!
This weekend is going to give everyone LOTS of time to do DD, get some dollars together, and hit the markets hard Monday morning!
Can't wait to see it!
Easy double at this stupidly cheap close... maybe more!
Enjoy your spring weekend!
GLTA!

 
***SP closed at 1.09 on April 1rst, OUCH! Keep pumping as you have no choice and Tripp burried you alive like the rest of the shareholders. 
<< Previous
Bullboard Posts
Next >>